Brain structural features of treatment resistant depression in a large Italian sample: A multimodal imaging study.
Abstract
Major depressive disorder is a common psychiatric condition characterized by persistent low mood, emotional dysregulation, and cognitive impairments affecting daily functioning. Approximately 30% of patients fail to respond adequately to at least two antidepressant trials, a condition known as treatment resistant depression (TRD), the neurobiology of which is still poorly understood. This study therefore aimed to investigate grey matter (GM) and white matter (WM) alterations associated with treatment resistance, directly comparing patients with TRD, treatment-sensitive depression (TSD), and healthy controls (HCs). MRI data were acquired from 294 individuals with MDD (193 TRD and 101 TSD) and 72 HCs. Group differences were assessed using analyses of variance followed by post-hoc t-tests. Compared with TSD patients, TRD patients showed reduced GM volume in striatal, temporal, and medial orbitofrontal regions. Relative to HCs, TSD patients exhibited localized GM reductions in the anterior cingulate cortex, whereas TRD patients showed extensive reductions across frontal, temporal, parietal, and limbic areas. Significant differences also emerged in WM microstructural integrity, as measured by fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD). Compared with both TSD patients and HCs, TRD patients exhibited widespread FA reductions paralleled by increased AD, RD, and MD values, whereas no significant differences emerged between TSD patients and HCs. These findings provide evidence that TRD is characterized by a distinct neurobiological profile, offering new insights into the mechanisms of treatment resistance that may ultimately facilitate the development of more effective, tailored therapeutic interventions.